What is the definition of febrile neutropenia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definición de Neutropenia Febril

La neutropenia febril se define como una temperatura oral única ≥38.3°C (101°F) o una temperatura ≥38.0°C (100.4°F) sostenida durante 1 hora, junto con un recuento absoluto de neutrófilos (RAN) <500 células/mm³, o <1000 células/mm³ con descenso previsto a ≤500 células/mm³. 1

Componentes de la Definición

Criterios de Fiebre

La fiebre en pacientes neutropénicos se establece mediante dos umbrales alternativos 1:

  • Temperatura oral única: ≥38.3°C (101°F)
  • Temperatura sostenida: ≥38.0°C (100.4°F) mantenida durante al menos 1 hora

Nota importante: Algunas guías europeas (ESMO) utilizan criterios ligeramente diferentes, definiendo fiebre como temperatura axilar >38.5°C durante >1 hora 1. Sin embargo, las guías más ampliamente adoptadas (IDSA, ASCO, NCCN) utilizan los umbrales de temperatura oral mencionados anteriormente 1.

Criterios de Neutropenia

El componente de neutropenia se define por el recuento absoluto de neutrófilos 1:

  • RAN ≤500 células/mm³ (equivalente a <0.5 × 10⁹/L), O
  • RAN ≤1000 células/mm³ (equivalente a <1.0 × 10⁹/L) con descenso previsto a ≤500 células/mm³ en las próximas 48 horas

Clasificación de Severidad

Las guías establecen categorías adicionales de neutropenia según severidad 1:

  • Neutropenia severa: RAN <500 células/mm³ (<0.5 × 10⁹/L)
  • Neutropenia profunda: RAN <100 células/mm³ (<0.1 × 10⁹/L)
  • Neutropenia prolongada: Duración ≥7 días

Importancia Clínica

La neutropenia febril constituye una emergencia oncológica que requiere evaluación y tratamiento antimicrobiano empírico inmediato. 2, 3, 4 La mortalidad asociada puede alcanzar 10-15% en pacientes hospitalizados, siendo la neutropenia profunda (RAN <100 células/mm³) el único factor predictivo consistente de mayor mortalidad 3, 5.

Advertencia Crítica

El retraso en el diagnóstico y tratamiento se asocia con mayor morbilidad y mortalidad 5. Los pacientes deben ser evaluados y recibir antibióticos de amplio espectro dentro de la primera hora del diagnóstico 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of the Management of Febrile Neutropenia in a Tertiary Care Center.

The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale, 2025

Research

Chemotherapy-Induced Febrile Neutropenia in Solid Tumours.

The Gulf journal of oncology, 2017

Related Questions

What is the recommended approach to managing febrile neutropenia in an adult patient who presents with a fever ≥38.3 °C (101 °F) or a sustained fever ≥38.0 °C (100.4 °F) for more than one hour and an absolute neutrophil count (ANC) <500 cells/µL (or expected to fall below 500 cells/µL within 48 hours)?
What is the recommended initial management for a patient with febrile neutropenia, including antibiotic selection, duration, and supportive measures?
What is the definition of febrile neutropenia, including the absolute neutrophil count and temperature criteria, and what is the recommended initial empiric management?
What is the recommended management for a patient with febrile neutropenia?
What is the recommended management of febrile neutropenia in a pediatric patient?
In a patient with an uncomplicated urinary tract infection (UTI) whose culture shows penicillin susceptibility, what is the recommended duration of oral penicillin therapy?
What non‑hormonal integrative management strategies can be used for a 45‑60‑year‑old menopausal woman with vasomotor symptoms, sleep disturbances, mood changes, or urogenital discomfort?
In a 75-year-old man with chronic mild hyponatremia (serum sodium 133 mmol/L), modestly elevated amylase, normal lipase, and a normal pancreas on abdominal ultrasound, what is the appropriate next step in management?
In a patient with normal cerebrospinal fluid analysis and normal brain and spine MRI who has widespread paresthesias and abnormal F‑wave studies, what is the most likely diagnosis and recommended treatment?
Can ertapenem be administered intramuscularly, and what is the recommended duration of therapy?
How should anemia of prematurity be managed in a preterm infant (<32 weeks gestation or <1500 g), including transfusion thresholds, iron supplementation, and erythropoietin therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.